Skip to main content

Table 1 Experimental groups.

From: Prevention of Neutrophil Migration Ameliorates Rat Lung Allograft Rejection

Groups

n

Antileukinate administration

TST, min

GIT, min

A

6

2 doses of 10.0 mg/kg/d, bolus injection; im 24 h before and immediately after surgery

140.3 ± 7.4

109.7 ± 3.6

Cont-A

6

None*

130.8 ± 7.9

104.0 ± 7.6

B

8

Continuous, ip 10.0 mg/kg/d, days 0 to 7

140.6 ± 24.5

113.3 ± 24.0

Cont-B

8

None*

138.8 ± 17.6

107.3 ± 15.2

  1. *Each control group was given PBS in the same manner as its respective treated group. im, intramuscular; ip, intraperitoneal using micro-osmotic pumps; TST, total surgical time (from beginning of thoracotomy to end of surgery); GIT, graft ischemic time (from donor lung flush to reperfusion).
Back to article page

Molecular Medicine

ISSN: 1528-3658